Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.30567/fullpdf
Reference76 articles.
1. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks;Cohen;Arthritis Rheum,2006
2. Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers;Dorner;Pharmacol Ther,2010
3. Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes;Mitchell;J Exp Med,1968
4. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice;Bouaziz;Proc Natl Acad Sci U S A,2007
5. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease;Lund;Curr Dir Autoimmun,2005
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases;Journal of Autoimmunity;2024-09
2. A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome;JCI Insight;2022-12-08
3. CD4+ count‐dependent concentration–effect relationship of rituximab in rheumatoid arthritis;British Journal of Clinical Pharmacology;2019-11-22
4. Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire;Annals of the Rheumatic Diseases;2019-06-19
5. Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis;Rheumatology;2019-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3